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Abstract. Performance assessment of instruments devised for clinical applications is of key importance for
validation and quality assurance. Two new protocols were developed and applied to facilitate the design and
optimization of instruments for time-domain optical brain imaging within the European project nEUROPt. Here,
we present the “Basic Instrumental Performance” protocol for direct measurement of relevant characteristics.
Two tests are discussed in detail. First, the responsivity of the detection system is a measure of the overall
efficiency to detect light emerging from tissue. For the related test, dedicated solid slab phantoms were devel-
oped and quantitatively spectrally characterized to provide sources of known radiance with nearly Lambertian
angular characteristics. The responsivity of four time-domain optical brain imagers was found to be of the order of
0.1 m2 sr. The relevance of the responsivity measure is demonstrated by simulations of diffuse reflectance as
a function of source-detector separation and optical properties. Second, the temporal instrument response func-
tion (IRF) is a critically important factor in determining the performance of time-domain systems. Measurements
of the IRF for various instruments were combined with simulations to illustrate the impact of the width and shape
of the IRF on contrast for a deep absorption change mimicking brain activation. © The Authors. Published by SPIE under a
Creative Commons Attribution 3.0 Unported License. Distribution or reproduction of this work in whole or in part requires full attribution of the original
publication, including its DOI. [DOI: 10.1117/1.JBO.19.8.086010]
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1 Introduction
In recent years, instruments and methodologies to noninvasively
probe human tissues by diffuse light in the near-infrared spectral
range have undergone translation from laboratory bench to
bedside. For example, clinical trials have been performed target-
ing the female breast. Optical mammography has been devel-
oped and applied to detect and characterize breast lesions,1,2
as well as to monitor the outcome of neoadjuvant chemotherapy
of the breast.3,4 Diffuse optical spectroscopy is a promising tech-
nique for cancer risk assessment.5,6 In parallel, many clinical
studies have been conducted targeting the brain. Optical imag-
ing has been used to observe the hemodynamic response to
cognitive, sensory, and motor stimuli,7 and to assess changes
associated with traumatic brain injury,8 stroke,9 and epilepsy,10
with the aim of providing a less expensive and portable alter-
native to the existing neuroimaging techniques such as magnetic
resonance imaging or x-ray computed tomography. Meanwhile,
optical techniques have also been applied to other tissues such as
muscle, joints, bone, and skin as a means of providing diagnos-
tic information.
One of the principal impediments to a widespread adoption
of optical imaging techniques in the clinic has been the difficulty
in providing absolute physiological parameters from optical
measurements. Even when the individual systems demonstrate
excellent repeatability, the derived parameters are often system
specific. Progress has been hampered by the lack of standardi-
zation and quality assessment tools, which would enable
measurements acquired with one system to be compared with
those acquired with another.11 Appropriate protocols are clearly
required in order to assess the performance of one instrument
against another or to assess subsequent upgrades of the same
system. The availability of such protocols may also be beneficial
during research and development of methods and devices—par-
ticularly at an industrial level—toward an improvement in the
measurement of those parameters that are relevant to specific
clinical applications. Standardized procedures for characteriza-
tion of instruments and techniques would also facilitate a more
reliable comparison between data acquired on a given system for
different clinical studies. The large variety of measurement tech-
niques (e.g., continuous wave, frequency, and time domain),
instrument configurations (e.g., multichannel imagers and sin-
gle-channel monitor),12 and clinical applications makes it even
more desirable that a simple, well-defined procedure exists for
testing and validating the relevant optical systems.
*Address all correspondence to: Heidrun Wabnitz, E-mail: heidrun.wabnitz@
ptb.de
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In the field of diffuse optical imaging and spectroscopy, the
first systematic study of various instruments was performed
within a European Thematic Network on the basis of the
MEDPHOT protocol.13 Recently, the development and testing
of phantoms have been reported for quality assurance in a
multicenter clinical trial to measure the response of breast
tumors to neoadjuvant chemotherapy by means of diffuse
optical imaging.14
The work presented here was carried out within the European
project nEUROPt (FP7-HEALTH-F5-2008-201076) that con-
cerned the development of time-domain systems for optical
imaging of the brain based on novel technological advances
and new methodological approaches. The new methodologies
were evaluated with respect to their potential to improve the
spatial resolution, sensitivity, and quantification of optical
properties. Two new protocols were developed to provide
guidelines for the comparison of various instruments and to
estimate the impact of new technological and methodological
advances on performance, namely the BIP protocol for “Basic
Instrumental Performance” assessment and the nEUROPt pro-
tocol for performance assessment of time-domain brain imagers.
These protocols were employed for a series of common mea-
surements performed by contributing project partners within
the nEUROPt project and were also used for quality assurance
purposes, particularly during clinical studies.
Overall, the three BIP, MEDPHOT, and nEUROPt protocols
constitute a consolidated and integrated framework for the per-
formance assessment of time-domain instruments in diffuse
optics, with already broad consensus and experimental use
among many EU laboratories. The key features of all three pro-
tocols are summarized in Table 1. The BIP protocol is focused
on the key properties of the systems on a basic level, indepen-
dent of the sample properties to be measured and of the related
data analysis methods. In particular, it deals with the detection
efficiency of the system, with its temporal performance charac-
terized by the instrument response function (IRF), and a number
of other key parameters to be collected. The MEDPHOT pro-
tocol is a subsequent “high-level” protocol intended to grade
the capability of the system taken as a whole—including
the analysis software—to retrieve the optical properties of a
homogeneous medium, with emphasis on the features that
are most relevant for the clinical application. In particular, it
is configured to characterize the measurement of the absorp-
tion (μa) and reduced scattering (μ 0s) coefficients of a turbid
medium in terms of accuracy, linearity, noise, stability, and
reproducibility. Finally, the nEUROPt protocol represents
another “high-level” protocol, based on specific inhomo-
geneous phantoms, to test the performance of an imaging
device. It addresses the ability of optical brain imaging systems
to detect, localize, and quantify absorption changes in the
brain. The BIP tests play an important role in the interpretation
of the results of these high-level protocols, particularly when
combined with appropriate simulations.
The present work is devoted to the BIP protocol, while the
nEUROPt protocol will be introduced in a companion paper.15
After a description of the individual tests and their implemen-
tation in the following section, the application of the protocol is
illustrated by presenting and discussing results obtained using
several instruments developed by four different laboratories.
2 BIP Protocol
This protocol concerns the recording of basic characteristics of
time-domain instruments, which influence the quality and accu-
racy of measurements in clinical applications. It is applicable to
instruments based on pulsed laser sources with repetition rates
of the order of several tens of MHz, fast single-photon detectors,
and time-correlated single photon counting (TCSPC). The pri-
mary measurand is the histogram of photon flight times NðtÞ,
usually denoted as the temporal point spread function or the dis-
tribution of times of flight (DTOF). The tests of this protocol
aim to assess factors that influence the quality of the measured
Table 1 Overview of protocols for performance characterization of instruments in diffuse optics (cw—continuous wave, fd—frequency domain,
and td—time domain).
Protocol BIP MEDPHOT13 nEUROPt15
Key features Purpose Characterization of an instrument
without a measuring object
Capability of an instrument to
measure homogeneous
optical properties
Capability of an instrument to
detect, localize, and quantify
absorption changes
Target quantities Characteristics of source and
detection component and
temporal IRF
Absolute homogeneous μ 0s and μa Δμa of an inhomogeneity
Models for
data analysis
— Model-based retrieval of
homogeneous μ 0s and μa
Model-based retrieval of Δμa or
semi-empirical data analysis
Spatial aspects — — Tests for spatial localization of Δμa
Reference
implementation
Phantoms Responsivity phantom (as diffuse
light source)
Set of solid homogeneous
phantoms with different
μ 0s and μa
Inhomogeneous liquid phantoms
with (a) inclusions and (b) two
layers
Application Primary fields td photon migration instruments Photon migration instruments of
any kind
td optical brain imagers
Possible extension cw and fd photon migration
instruments; other td instruments
cw and fd optical brain imagers;
optical mammographs
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distribution NðtÞ, in particular its shape, signal-to-noise ratio,
and stability.
The instruments under test can be subdivided into a source
component and a detection component. The source component
consists of one or more lasers and the means to deliver light to
the tissue, e.g., an optical fiber. The detection component com-
prises a fast single-photon detector, TCSPC electronics, and
the optics (including e.g., a fiber bundle) to transport light from
the tissue to the detector. The tests of this protocol address:
1. Relevant parameters of the source component of the
instrument,
2. The responsivity of the detection system,
3. The differential nonlinearity (DNL) of the timing elec-
tronics, and
4. The temporal IRF, its shape, its background, as well as
its stability.
Test (1) covers the separate characterization of the source
component, while tests (2) and (3) are related only to the detec-
tion component. The IRF (test 4) depends on the properties of
both components. Tests (1) and (2) address the time-integrated
efficiency of the instrument, while tests (3) and (4) concern the
characteristics of the time-resolved measurement. All four tests
are briefly presented below. In Sec. 4, we will focus on the
results related to tests (2) and (4) and discuss their implications
in the context of in vivo time-domain optical brain imaging.
2.1 Source Parameters
The source component of the instrument usually comprises one
or more pulsed lasers (possibly of tunable wavelength), attenu-
ators, coupling free-space optics, and/or fiber optics (e.g., one or
more source fibers, fiber splitters/combiners, or fiber switches).
The following parameters are most relevant for characterizing
this component: (1) average laser output power Plaser (at
given repetition rate); (2) center wavelength and width of the
laser output spectrum; (3) average laser power delivered to
the sample at the source optode(s) Psource; and (4) illuminated
area Asource on the surface of the sample. A high Psource is desir-
able to increase the signal-to-noise ratio, although safety consid-
erations limit the (total of all wavelengths) source power per unit
area. Increasing Asource enables Psource to be increased, but a too
large Asource may compromise (lateral) spatial resolution.
2.2 Responsivity of the Detection System
The efficiency of detecting low light levels emerging from tissue
is crucial for any in vivo photon migration measurement. In gen-
eral, the responsivity of a detector is the ratio between the mea-
sured signal and the magnitude of the input illumination. In the
context of the instruments considered here, this is the ratio of the
photon count rate and the amount of light emitted by the tissue
directly beneath the detector optode. Light emerging from tissue
after diffusive propagation can (under certain conditions) be
modeled by a uniform Lambertian source16,17 with photon radi-
ance Lp (in s−1 m−2 sr−1). The cos Θ angular distribution (Θ—
angle with the surface normal) is a reasonable approximation in
the diffusion regime and for a ratio >1 of the refractive index
inside and outside the turbid medium. The lateral uniformity is
fulfilled if the detection area is sufficiently far from the source.
The spectral responsivity of the detection system with respect
to photon radiance is obtained from the count rate divided by the
input photon radiance
sLdetðλÞ ¼ N˙det∕LpðλÞ; (1)
where the detected count rate N˙det is equal to the time-integrated
total photon count Ntot divided by the measurement time tmeas. It
should be noted that sLdet addresses the overall sensitivity, irre-
spective of time resolution.
To facilitate the understanding of the responsivity of the
detection system, the following equation illustrates its major
components:
sLdetðλÞ
¼AηdetðλÞηTCSPC
Z
2π
0
dΦ
Z
Θmax
0
cosΘTopticsðΘ;A;λÞsinΘdΘ;
(2)
where A is the tissue area from which light is collected, ηdet is the
quantum efficiency of the detector, and ηTCSPC is the efficiency
of recording single-photon pulses generated by the detector. The
integration over the solid angle is performed up to a maximal
polar angle Θmax, usually restricted by the numerical aperture
(NA) of the detection fiber or fiber bundle. The transmittance
Toptics of the whole relay optics between tissue and detector
includes any losses in the detection fibers or fiber bundles
and the (in part angle-dependent) efficiency of light transfer
to the detector. The dependence of Toptics on A symbolizes
the limitations introduced, e.g., by the finite area of the detector
or vignetting in the optical path. The efficiency ηTCSPC may be
influenced by clipping of the single-photon pulse-height distri-
bution by the discriminator threshold, by incomplete recording
of the photon histogram or, at very high count rates, by dead-
time effects. Many of these factors are not precisely known for a
given system, and thus calculating the responsivity according to
Eq. (2) would involve significant uncertainty. Therefore, we pro-
posed to directly measure the responsivity.
The measurement of sLdet requires an approximately uniform
Lambertian source of known photon radiance. To realize such
sources, integrating spheres are often used. However, they are
not easy to handle when comparing different instruments in dif-
ferent locations. Therefore, in the present work, dedicated thick-
slab phantoms with known diffuse transmittance were used as
working standards. These turbid slab phantoms transform a
given input power Pin (continuous wave or time averaged)
from a collimated pencil laser beam into a known wave-
length-dependent photon radiance at the exit surface opposite
to the laser beam (in a transmission geometry). Input power
and output photon radiance are related via the equation
LpðλÞ ¼ κpðλÞPinðλÞ; (3)
where κpðλÞ is a phantom-specific photon transmittance factor
(in units of W−1 s−1 m−2 sr−1). This factor includes a transfor-
mation of a power (W) into a photon-related quantity, which
makes it easy to apply. Combining Eqs. (1) and (3), the respon-
sivity of the detection system can be measured as
sLdetðλÞ ¼ Ntot∕½tmeasκpðλÞPinðλÞ: (4)
The unit of sLdet is m
2 sr.
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It is worth noting that there is a straightforward relationship
between κpðλÞ and the time-integrated diffuse transmittance T tot
of the slab phantom opposite to the source position
T totðλÞ ¼ πκpðλÞEphotðλÞ; (5)
where Ephot ¼ ðhc∕λÞ is the photon energy. The factor π results
from integration over the full hemisphere assuming a
Lambertian distribution.
2.3 DNL of the Timing Electronics
The DNL is the nonuniformity of the time channel width in a
TCSPC system.18 Since the number of photons collected in a
given channel is proportional to the channel width, any non-
uniformity appears as a modulation in the recorded photon
distribution NðtÞ. It can result in systematic errors in TCSPC
measurements. In most cases, DNL problems are due to the elec-
tronic crosstalk between start and stop pulse signals or the spu-
rious pickup of start- or stop-related signals, such as from laser
drivers, and can often be avoided by adequate shielding of detec-
tors and cables. It is important to identify such problems with a
DNL measurement. Since they may change when changing the
configuration of the instrument or moving it to another location,
a routine DNL test is mandatory for quality assurance.
The DNL is recorded as a response to a continuous signal. A
battery-powered light source is preferable to avoid any electrical
interference. To obtain the DNL with a good signal-to-noise
ratio, each time channel should contain ≥105 counts. Ideally, the
photon counts in all time channels are expected to be equal, i.e.,
NDNLðtÞ should be constant in this case. The deviation from this
situation is characterized by the peak-to-peak difference normal-
ized to the mean value
εDNL ¼
NDNL;max − NDNL;min
NDNL
: (6)
A correction of measured NðtÞ can be performed by numeri-
cal equalization of the width of time channels based on NDNLðtÞ
as a measure of their nonuniformity. It is only required if εDNL
exceeds a few percent.
2.4 Temporal IRF
Whereas the tests described above are related to the source or
detection component alone, the IRF characterizes the time res-
olution of the instrument as a whole. Exact knowledge of the
IRF is crucial for any model-based reconstruction of tissue
optical properties. The IRF is measured by inserting a reference
sample between source and detection components of the instru-
ment which contributes a negligible additional temporal
dispersion. The IRF depends on the laser pulse shape, the
temporal response of the detector and electronics, and pulse
broadening due to temporal dispersion in the fiber-optics, and
is represented as a convolution of these individual effects.
Regarding fiber dispersion, it is essential that the IRF measure-
ment adequately duplicates the conditions of the measurements
on tissue, i.e., the angular distribution of the collected light
must be similar, which normally implies filling the acceptance
angle of the detection fiber or fiber bundles.19 This is achieved
by employing a reference sample consisting of a layer of
highly scattering material, e.g., sheets of paper or Teflon tape,
small and thin enough to avoid pulse broadening by multiple
scattering within the layer itself.20 To obtain an IRF shape
over a wide dynamic range with a good signal-to-noise ratio,
a total photon count of at least 106 is recommended. Data over-
flow in the peak region can be avoided by summing up repeated
measurements, e.g., of 1-s duration.
It is common to characterize the IRF by its full-width-at-half-
maximum (FWHM). However, since long flight-time photons
are often of particular interest in time-domain brain imaging,
the shape of the trailing edge of the IRF is also important.
Signals produced by photomultipliers (PMTs) sometimes
exhibit afterpeaks, caused by afterpulses with a short delay21
occurring up to a few nanoseconds after the main peak.
Meanwhile, single-photon avalanche diodes typically exhibit
an exponentially decaying diffusion tail. To study the influence
of such features on a measurement, the full profile of the IRF has
to be taken into account rather than a single or a few parameters.
Another important characteristic of the IRF is the back-
ground that influences the dynamic range. A signal-independent
component of the background due to dark counts and residual
ambient light can be obtained from a “dark” measurement with
the laser source removed. In addition, PMTs often have a signal-
dependent background due to afterpulsing caused by positive
ions.18 These afterpulses occur on the time scale of a few micro-
seconds after a single-photon pulse. At laser repetition rates of
several 10 MHz, these afterpulses accumulate and lead to a
virtually temporally constant, signal-dependent background
component. A comprehensive characterization of afterpulsing
employs an autocorrelation measurement of detected pulses.18
In the present work, we propose another, more simplified
approach, i.e., the calculation of an “afterpulsing ratio” directly
from an IRF and a “dark” measurement. This ratio relates the
total counts in the background, after subtraction of the dark
background and rescaling to the full laser period T laser (recipro-
cal repetition rate), to the total counts in the IRF signal Ntot;IRF
(after background subtraction):
RAP ¼
ðNmean;bkg − Nmean;darkÞ
Ntot;IRF
T laser
Δt
; (7)
where Nmean;bkg and Nmean;dark are the mean values of the back-
ground in the IRF measurement and in the “dark” measurement,
respectively, and Δt is the time channel width (typically of the
order of 10 ps). Nmean;bkg is determined within an IRF interval of
constant background level. It should be noted that the method
described here cannot distinguish between the detector after-
pulsing background and possible time-independent laser back-
ground radiation. However, the types of lasers which are rel-
evant here do not exhibit such a background.
Finally, the stability of the IRF is another relevant factor for
the capability of a time-domain brain imager to measure small
physiologically induced changes in photon flight time (e.g.,
due to a functional stimulation of the brain). It is essential to
know how quickly the entire system (including the sources,
the detectors, and the electronics) reaches thermal equilibrium.
We characterized the stability by continuously recording the
IRF for at least 1 h after switching on the instrument and by
analyzing the total intensity, the temporal position, and the
shape of the IRF. Such recordings also provide a measure of
the fluctuations in these parameters once the initial stabilization
phase is completed.
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2.5 Summary of the Protocol and Its
Implementation
Table 2 provides an overview of the tests described above,
together with the recommended count rates and measuring
times for those involving TCSPC measurements. Note that
the recommended measuring time typically consists of a number
of repeated measurements with a collection time of 1 s, short
enough to avoid a memory overflow. All tests should be per-
formed when initially characterizing an instrument, and then
repeated following any relevant modification of its components
or settings. Some of the measurements, highlighted by ðÞ in
Table 2, are recommended for daily quality control testing, par-
ticularly during clinical studies.
Together with the results of the tests and the related specific
parameters, it is essential to record the configuration of the
instrument with its specific components and all relevant settings
of lasers, detectors, and electronics. For our study, we developed
and employed a set of spreadsheets to keep track of all this infor-
mation and to facilitate the comparison of different instruments.
3 Experiment
3.1 Instruments
The various instruments (including, in some cases, several dif-
ferent versions of them), whose performances were assessed
according to the BIP protocol, are listed in Table 3. The major
goals of the present work were to (1) characterize and compare
the time-domain brain imagers of the various participating
groups and (2) study the effect of modifying components and
configurations during the process of development and
optimization.
Five time-domain optical brain imagers were assessed
including their modified versions and a laboratory system for
broadband time-domain diffuse spectroscopy. The four brain
imagers of PTB, IBIB, and POLIMI (for abbreviations, see cap-
tion of Table 3) were developed mainly for depth-selective func-
tional near-infrared spectroscopy (fNIRS) on adults. In each
case, the optical sources consisted of picosecond diode lasers
at either two or three wavelengths: one around 690 nm and
one around 830 nm, and a third optional wavelength in between.
The spectral width was typically less than 5 nm. The repetition
rates were chosen between 40 and 80 MHz. The laser power
exiting the source optodes ranged from several tenths of milli-
watts to a few milliwatts. The detection components of these
instruments consisted of compact fast PMTs, preamplifiers,
and multiboard TCSPC systems. The various brain imagers
mainly differed in the particular type of PMTs, the optical
systems, and fiberoptic components. These characteristics are
summarized in Table 3. The setups PTB_2 and IBIB_2 were
based on the original brain imagers, but equipped with alterna-
tive detectors. The UCL monstir-II system has been developed
to perform three-dimensional optical tomography of the entire
newborn infant brain, with special focus on imaging slow hemo-
dynamic activity associated with seizures. It was based on 32
photon counting PMTs, a TCSPC module (SPC-630, Becker
& Hickl GmbH, Berlin, Germany), and a tunable supercontin-
uum pulsed laser (Fianium Ltd., Southampton, United
Kingdom). The laser, combined with a pair of acoustic-optic
tunable filters (AOTFs), enabled data to be simultaneously
Table 2 Test measurements and recommended parameters; ðÞ—recommended as daily routine tests. Measurements with picosecond time
resolution are indicated by t , while T represents the time scale of minutes to hours.
Part of
instrument Test quantity Measurements Count rate Measuring time Analysis Remarks
Source
component
Laser power P laser Measure source parameters
for all source optodes and
wavelengthsSource power ðÞ Psource
Area Asource
Wavelength λ, Δλ
Detection
component
Responsivity sLdet P in Eq. (4) Use slab phantom with known
κpðλÞ (see Sec. 3.2). Attenuate
source power by filters to
adjust the count rate
N tot <0.5 × 106 s−1 20 × 1 s
Differential
nonlinearity ðÞ
NDNLðtÞ 1 × 106 s−1 1 × 100 s Eq. (6) Use continuous light source
(battery powered). Same
TCSPC settings as in main
experiment
Entire system
(IRF)
IRF profile ðÞ N IRFðtÞ 1 × 106 s−1 20 × 1 s E.g., FWHM; full
profile for simulations
Use thin diffuser to fill the entire
acceptance angle of detection
fiber or bundle
Afterpulsing
ratio RAP
N IRFðtÞ
NdarkðtÞ
1 × 106 s−1 20 × 1 s 20 × 1 s Eq. (7)
IRF stability N IRFðt ; T Þ 1 × 106 s−1 3600 × 1 s E.g., N totðT Þ, m1ðT Þ Extend measuring time
necessary to reach stability.
Record room temperature in
parallel
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recorded at any combination of four wavelengths, selected
within the range from 600 to 880 nm. The laboratory system
POLIMI_3 was devised for high time resolution and coverage
of a wide spectral range. It was based on a Ti:sapphire laser and
a microchannel-plate PMT (MCP-PMT). All PMTs were manu-
factured by Hamamatsu Photonics, Hamamatsu, Japan; HPM-
100-50 is a hybrid detector module (Becker & Hickl GmbH)
based on a Hamamatsu R10467 tube.33
3.2 “Responsivity” Phantoms
These phantoms were not intended to represent a standard for
certain scattering and absorption properties, but rather for (time-
integrated) diffuse transmittance. A set of solid, virtually iden-
tical phantoms was prepared, characterized, and distributed to
the project partners. The five cylindrical solid phantoms were
made of epoxy resin with TiO2 particles added as a scattering
medium and black toner as the absorbing medium, following the
recipe published by Swartling et al.34 The reduced scattering and
absorption coefficients were of the order of 1 and 0.01 mm−1,
respectively. The phantoms were machined into a set of 10
cylindrical slices with a 2-cm thickness, 10.5-cm diameter,
and smooth surfaces. For the following characterization, 5
out of the 10 phantoms were selected for best homogeneity
in the central region. Black PVC housings were manufactured
with central openings on both sides to attach any specific opto-
des. Figure 1(a) shows one of the phantoms.
The diffuse transmittance factor κpðλÞ of these phantoms was
measured using the arrangement illustrated in Fig. 1(b). An
SC500-6-custom supercontinuum laser with AOTF (Fianium
Ltd., Southampton, United Kingdom) was used as a tunable
light source. The measurement was repeated at two wavelengths
(686 and 808 nm) with more stable picosecond diode lasers
(Sepia II, PicoQuant GmbH, Berlin, Germany). The collimated
laser beam (diameter < 5 mm) was directed onto the center of
the surface of the phantom via an aperture in the housing of
diameter 8.5 mm. Light diffusely transmitted through the phan-
tom was able to pass through another housing aperture, of
diameter 2r1 ¼ ð5.00 0.05Þ mm, immediately opposite to
the entrance aperture. A Si-photodiode detector (S1338-
1010BQ, Hamamatsu Photonics) was located at a distance d ¼
ð92.0 0.5Þ mm from the exit surface of the phantom. A
diaphragm immediately in front of the photodiode, slightly
tilted at 5 deg, had an area determined radiometrically as
A2¼ ð51.43 0.17Þ mm2. The average power of the main
beam Pin;0ðλÞ (several milliwatts) was measured before and
after the set of phantom measurements (i.e., all phantoms at
all wavelengths) using a calibrated thermopile powermeter
(LabMax with head PS19Q, Coherent Inc., Santa Clara,
California). The reference power measurements recorded
Table 3 Characteristics of the detection part of the instruments and their modified versions participating in the comparison. Codes (acronyms of
institutions; for complete information, see author affiliations): PTB—Physikalisch-Technische Bundesanstalt, IBIB—Nałęcz Institute of
Biocybernetics and Biomedical Engineering, and POLIMI—Politecnico di Milano, UCL—University College London; the codes of the instruments
are consistent with those used in the companion paper15 parameters of collection fibers or fiber bundles:D—diameter, L—length, and NA—numeri-
cal aperture.
Code Instrument Detector type (photocathode, diameter)
Detection fiber or bundle
ReferencesD (mm) L (m) NA
PTB_1 Brain imager “BI-1” R7400U-02 (multialkali, 8 mm) 4 1.5 0.54 9, 22, 23
PTB_2 – with alternative detector modules H7422-50 (GaAs, 5 mm) 4 1.5 0.54 24
IBIB_1 Brain imager R7400U-02 (multialkali, 8 mm) 4 1.5 0.54 25, 26
IBIB_2 – with direct detector R7400U-02 (multialkali, 8 mm) – – – 27
POLIMI_1 Brain imager “fOXY” R5900U-20-M4 (multialkali, 9 mm square) 3 1.5 0.57 28, 29
POLIMI_2 Brain imager “fOXY2” HPM-100-50 (GaAs, 3 mm) 3 1.5 0.57 30
POLIMI_3 Diffuse spectrometer MCP-PMT R1564U (S1) 1 1.5 0.39 31
UCL Neonatal brain imager “monstir-II” H8224P-50 (GaAs, 5 mm) 3 2.5 0.21 32
Fig. 1 (a) Responsivity phantom. (b) Setup to measure the diffuse transmittance factor κpðλÞ.
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throughout the phantom measurements were used to correct
for changes in power during the experiment. The photocurrent
(several nanoampere) was recorded using a Keithley 6485
picoamperemeter. The spectral irradiance responsivity sEðλÞ
(AW−1 m2) of the Si photodiode had been calibrated before
in the Department of Detector Radiometry and Radiation
Thermometry of PTB. The radiation was measured in a small
solid angle around the optical axis.
The photon radiance emerging from the phantom was
derived as
Lp;0ðλÞ ¼
IphotoðλÞ
sEðλÞG
λ
hc
; (8)
where G ¼ πr21∕d2 is the geometry factor. The diffuse transmit-
tance factor is calculated from
κpðλÞ ¼ Lp;0ðλÞ∕Pin;0ðλÞ: (9)
Figure 2 shows the result of the characterization of the phan-
toms. The individual phantoms had rather different transmittan-
ces, although this is irrelevant for their application since their
actual transmittance factors were measured. The phantom
slabs 2o, 2u and 4o, 4u, respectively, which were cut from
the same epoxy resin blocks, exhibited nearly the same trans-
mittance factors. Equation (5) allows the time-integrated diffuse
transmittance of the phantom opposite to the source position to
be derived. A typical value of κp ¼ 1 × 1020∕ðWsm2 srÞ at λ ¼
750 nm corresponds to T tot ≈ 0.83 × 10−4 mm−2.
The wavelength dependence κpðλÞ could be reasonably well
approximated by a linear relationship. This feature facilitates the
application for any wavelength within the range investigated.
The overall relative uncertainty of κpðλÞ, including the applica-
tion of the linear approximation, was estimated to be <10%.
The comparability of responsivity measurements (at the same
wavelength) using different phantoms from the set was much
better. The corresponding relative uncertainty due to instrumen-
tal noise was <1% (standard deviation).
The thickness of the responsivity phantom is a parameter that
not only is important to achieve a good spatial uniformity of the
radiance within the acceptance area of the detector optode, but is
also essential for the choice of the method to measure κpðλÞ.
For the given optical properties, a thickness of 2 cm turned
out to be a reasonable compromise. For a much thicker slab,
the straightforward measurement of a photocurrent as described
above would no longer be feasible. The assumption of a
Lambertian characteristic was checked for the angular range that
is typically accepted by fiber bundles. The maximum deviation
from a cos Θ distribution in the range 0 < Θ < 30 deg was
found to be less than 3%.
4 Results and Discussion
In this section, we focus on the results related to the responsivity
of the detection system and the IRF. These measurements are
most relevant when assessing the performance of instruments
for clinical time-domain brain imaging. Exemplar simulations
illustrate the use of the results of these tests to predict specific
aspects of the performance in in vivo measurements.
4.1 Responsivity of the Detection System
4.1.1 Comparison of results for various instruments
The responsivity was measured for the various instruments as
described in Sec. 3.1 and Table 3. The results obtained for sev-
eral wavelengths are shown in Fig. 3. The data points pertaining
to the instruments POLIMI_1, POLIMI_2, IBIB_1, and IBIB_2
are each connected by dotted lines for clarity. The data for the
instruments PTB_1 and PTB_2 are given by symbols connected
by vertical solid lines to indicate ranges of responsivity. The
detection modules of both types (for PTB_1, see Ref. 22 and
for PTB_2, see Ref. 24) contained motor-driven variable attenu-
ators as well as iris diaphragms for independent control of the
effective NA. Both options were routinely used in in vivo mea-
surements to achieve an optimum count rate at a minimum effec-
tive NA, reducing the broadening effect of fiber dispersion on
the IRF as far as possible. The symbols marking the upper limits
of the ranges correspond to completely open diaphragms and
minimum attenuation. The values at the lower limits were
obtained for an effective NA of 0.15 and an attenuator transmit-
tance of 0.2. These lower settings were typical for measurements
on relatively “transparent” subjects, e.g., elderly patients.
It is interesting to note that the main brain imagers
POLIMI_1, IBIB_1, and PTB_1, devised for clinical studies,
Fig. 2 Wavelength-dependent diffuse transmittance factor κpðλÞ of
the five phantoms, together with linear approximation (star symbols—
additional measurements with picosecond diode lasers as sources).
For uncertainties see text.
Fig. 3 Responsivity of the detection system of various instruments as
a function of wavelength measured for the instruments listed in
Table 3. Codes (acronyms of institutions; for complete information,
see author affiliations): PTB_1 and PTB_2 was added for clarity.
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yielded very similar responsivity values, differing by a factor of
2 at most, in spite of employing different PMTs, fiber bundles,
and optical systems. This finding is one factor that enables the
comparability of the results of common in vivo studies. For these
systems, the responsivity clearly decreases with increasing
wavelength, which corresponds to the wavelength dependence
of the cathode sensitivity of the PMTs. For the detector module
with a gallium arsenide (GaAs) PMT (PTB_2), generally higher
sLdet values were measured with a flat wavelength dependence.
This behavior can be explained by the comparably high and
rather constant sensitivity of this photocathode type up to
about 850 nm. The brain imager POLIMI_2 that has a detector
with the same type of photocathode yet has a smaller diameter
(3 mm versus 5 mm for the H7422-50 PMT), shows a similar
wavelength dependence, but responsivity values closer to the
three main systems mentioned above. The neonatal brain imager
of UCL exhibited responsivity values about an order of magni-
tude lower. This is due to the longer detection bundle with a
comparably low NA and other aspects of the optics design.
The highest responsivity values were found for IBIB_2, i.e.,
a detector directly attached to the surface of the turbid medium
without any optics in between. Here, the full size of the photo-
cathode (diameter 8 mm) was effective. On the other hand, for
the laboratory system POLIMI_3, the responsivity at 750 nm
was considerably smaller. It should be noted that this system
was optimized for high time resolution and measurements
over a wide spectral range, employing, in particular, a detector
with an S1 photocathode of comparably low quantum yield and
a fiber of 1-mm diameter rather than a fiber bundle.
To facilitate the interpretation of the results, the following
considerations regarding maximum possible values are helpful.
Starting from Eq. (2) and assuming that ηdet, ηTCSPC, and Toptics
are all equal to 1, sLdet is determined by the area and the solid
angle over which light is collected. Theoretically, this product
cannot exceed A × π. The area A represents the smaller value of
the optode and detector areas, a realistic value being 10 mm2.
The factor π (for a Lambertian source) results from integration
over the full hemisphere. A maximum realistic aperture half-
angle of a fiber bundle is about 30 deg, which results in a factor
π∕4 instead and sLdet;max ∼ 8 mm2 sr. The values found for the
brain imagers remain about 1 to 2 orders of magnitude
lower, which can be explained by realistic quantum efficiencies
and losses in the optical systems.
4.1.2 Simulations: Implications for In Vivo Measurements
The responsivity of the detection system and the laser power
applied are the major instrumental determinants for the sig-
nal-to-noise ratio that can be achieved in an in vivomeasurement
at a certain source-detector separation. However, knowledge of
both values and the photon count rate allows the diffuse reflec-
tance Rtot of the tissue under investigation to be determined.
This relationship can be expressed as follows:
N˙det∕N˙in ¼ sLdetRtot∕π; (10)
where N˙in ¼ Pin∕Ephot is the input photon flux corresponding to
the input power, and N˙det is the count rate recorded by the detec-
tion system. Equation (10) was derived from Eq. (1) and uses the
relation Lp ¼ N˙inRtot∕π that is valid for a Lambertian angular
distribution.
Figure 4 displays the results of a simulation to estimate the
influence of the responsivity on the maximum source-detector
separation at which a good signal-to-noise ratio can be achieved.
According to our experience with in vivo time-domain fNIRS
measurements, the signal-to-noise ratio was usually sufficient
as soon as the count rate N˙det was at least 1 × 106 s−1. The
input power (1 mW at 800 nm) was chosen according to the
typical values for the brain imagers described in Sec. 3.1.
The simulation of the time-integrated diffuse reflectance Rtot
at separation r was based on the analytical solution of the
diffusion equation for a homogeneous semi-infinite medium
with extrapolated boundary conditions.35 Considering the case
where μ 0s ¼ 1 mm−1 and μa ¼ 0.01 mm−1, the given ratio of the
detected count rate and input power would be reached at a
source-detector separation r ¼ 5 cm for a responsivity value
in the range of those determined for the clinical brain imagers
POLIMI_1, IBIB_1, and PTB_1. A decrease in responsivity of 1
order of magnitude results in a decrease of the maximum r by
about 1 cm. The optical properties naturally have a substantial
influence on the maximum r. This fact is illustrated in Fig. 4 by
the curves for a factor of 2 higher and for lower values of μa and
μ 0s . If μa is increased from 0.01 mm−1 to 0.02 mm−1, then the
maximum r drops below 40 mm. Likewise, higher scattering
would prevent a measurement at a larger separation. It is
known that the intersubject variability of optical properties of
the head is substantial. It should be noted that the simulation
is based on assumed bulk optical properties while absorption
at the tissue surface due to skin color or hair beneath the optodes
additionally reduces the amount of light available for detection
in in vivo measurements.
An association with in vivo measurements can be established
from a recent study on stroke patients9 (brain imager PTB_1,
785 nm). The measurements were performed in the region of
the motor cortex, with a source-detector separation of 3 cm.
A count rate of ∼1 × 106 s−1 was typically achieved with
settings 0.15 for effective NA and 0.20 for attenuation, corre-
sponding to the lower limit of the range indicated for this instru-
ment in Fig. 3. With sLdet ∼ 1.3 × 10−3 mm2 sr and an input
Fig. 4 Maximum source-detector separation r at which a time-
resolved diffuse reflectance can be measured with good signal-to-
noise ratio, as a function of responsivity of the detection system.
The simulation was performed assuming an input power of 1 mW at
800 nm, a detected photon count rate of 1 × 106 s−1, absorption and
reduced scattering coefficients as indicated in the legend, and refrac-
tive index of the medium n ¼ 1.4. The vertical dotted line illustrates a
typical responsivity value found for the clinical brain imagers.
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power of 5 mW, a time-integrated diffuse reflectance of Rtot ∼
4 × 10−3 mm−2 can be inferred, a value close to the Rtot ¼ 5.5 ×
10−3 mm−2 obtained for the homogeneous optical properties
μ 0s ¼ 1 mm, μa ¼ 0.01 mm−1, and n ¼ 1.4. However, for mea-
surements on young adult subjects, particularly those with dark
hair, similar count rates could only be achieved with a consid-
erably increased responsivity.
4.2 IRF
4.2.1 Temporal profile
In this section, we present examples of measured IRFs for vari-
ous instruments and discuss the expected impact of their shape
on time-domain measurements of brain activation. Figure 5
shows the IRFs measured with three of the clinical brain imagers
and a laboratory system (see Table 3). After subtraction of a
constant background, all curves were normalized to their
maxima and shifted to peak at t ¼ 0.
The system POLIMI_3 with an MCP-PMT and supercontin-
uum laser has the best time resolution as characterized by the
FWHM, but also has a fast-decaying trailing edge. The IRFs
of the brain imagers are much wider with FWHMs of about
750 ps. This fact can be explained by the use of picosecond
diode lasers operated close to their maximum output power
and fiber dispersion effects in high-aperture fiber bundles.
Another feature of these IRFs is the occurrence of distinct
shoulders and afterpeaks on the trailing edge. They obviously
depend on the type of photocathode, which differs for the instru-
ments shown.
The influence of the shape of the IRF on time-domain fNIRS
measurements can be studied by combining simulations of light
propagation to mimic brain activation with measured IRFs. This
approach facilitates the interpretation of measurements on inho-
mogeneous phantoms as proposed in the nEUROPt protocol.15
The influence of the IRF shape on the contrast measured for a
deep absorbing perturbation (mimicking an absorption change
in the cortex) can be illustrated by means of the following exam-
ple using a simple simulation. An unperturbed DTOF was first
derived from the solution of the diffusion equation for a semi-
infinite homogeneous medium with a transport scattering coef-
ficient μ 0s ¼ 1 mm−1, absorption coefficient μa ¼ 0.01 mm−1,
refractive indices inside and outside the medium of 1.4 and
1, respectively, and employing extrapolated boundary condi-
tions. A source-detector separation r ¼ 2 cm was assumed. A
perturbation was then modeled as a point-like absorber accord-
ing to Ref. 36. The inhomogeneity was buried 1.5-cm deep in
the midplane between the source and detector. To define the
magnitude of the perturbation, the product of the change in
the absorption coefficient Δμa and the volume of the inhomo-
geneity was assumed to be 0.05 cm2. Figure 5(b) shows the nor-
malized DTOFs obtained for the pure simulation, corresponding
to a delta-pulse IRF, and after convolution with three noticeably
different cases of real IRFs that were selected from those plotted
in Fig. 5(a). The broad IRFs with afterpeaks cause a smaller dif-
ference between the unperturbed and the perturbed curves com-
pared to the ideal case (δ-IRF). A decrease in the contrast, i.e.,
the relative difference with and without perturbation, is particu-
larly evident in the region influenced by a strong afterpeak such
as that for the system PTB_2. The presence of an afterpeak in
the system IRF causes a small fraction of shorter-flight-time
photons to be detected within the tail of the DTOF, thus con-
taminating a measurement of later arriving photons and reducing
the contrast. On the contrary, a narrow IRF with a fast decaying
tail (POLIMI_3) only has a minor influence on the contrast. It
should be noted that this influence of the IRF on contrast could,
in principle, be eliminated by deconvolving the IRF from a mea-
sured DTOFs prior to calculating the contrast.
Figure 6 displays the relative contrast obtained from a time-
window analysis for the simulated DTOFs based on all IRFs
from Fig. 5(a). For the ideal case (δ-IRF), the absolute value
of the contrast for the deep inclusion is low for short photon
flight times, but increases monotonically at longer flight times.
The narrow IRF of POLIMI_3 leads to contrast values that are
only slightly worse than those of the δ-IRF case. The finite
FWHM only has a marginal influence, since it is small com-
pared with the width of the DTOF. However, the three broad
IRFs with afterpeaks lead to substantially lower absolute con-
trast values. In particular, an imprint of the shape of the should-
ers and afterpeaks on the IRFs can be discerned in the shape of
the contrast curve as a function of the position of the time win-
dow. The temporal position of these imprints not only depends
on the IRF, but also on the amount of broadening in the medium
which is, e.g., influenced by the source-detector separation (data
not shown).
Fig. 5 (a) Instrument response functions (IRFs) of several instru-
ments (see Table 3). (b) Simulated distributions of times of flight
(DTOFs) for a homogeneous semi-infinite medium without (solid
lines) and with (dashed lines) deep absorption perturbation (see
text) for a delta-pulse IRF and after convolution with three of the
IRFs shown in (a). Each curve is normalized to the maximum of
the corresponding unperturbed curve.
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Note that the time-window analysis (Fig. 6) was performed in
only a part of the full time range of Fig. 5. At much later times,
the decrease in signal will be too significant to maintain a rea-
sonable signal-to-noise ratio. A contrast-to-noise analysis for the
time-window approach would be a logical continuation of this
analysis but is beyond the scope of the present paper.
4.2.2 Stability
Measurements of the IRF stability are relevant to (1) determine
the duration of the necessary warm-up phase prior to in vivo
measurements and (2) assess fluctuations after completion of
the warm-up. From a time series of IRF measurements, two
characteristics of the temporal profile are derived, i.e., the inte-
gral Ntot and the first momentm1. The first moment is calculated
as m1 ¼
P
b
i¼a iNi∕Ntot · Δt from the counts Ni in the time
channels (width Δt) of the histogram memory between limits
a and b. The integral reflects the changes in laser power and
also in detector sensitivity, e.g., due to changes in the high volt-
age supplied to the PMTs. The first moment provides informa-
tion about timing drifts and jitter.
Figure 7 shows exemplar stability results for the total photon
count and the first moment of the IRF. Both integration limits (a,
b) were set at 1% of the maximum. The results for the
POLIMI_2 brain imager are related to the laser operating at
830 nm and were measured every 1 min with a collection
time of 1 s at a count rate of about 106 s−1. Similar results
were obtained for the second wavelength and for the other detec-
tors of this instrument. The integral varied by about 5% over 7 h
with a rather monotonic decrease within the first 2 h after system
switch-on. After about 100 min, subsequent intensity variation
was less than 1%. The first moment varied by about 250 ps in
total, but after 300 min, subsequent variation was within 5 ps.
The major reason for the observed drift is the (thermal) stabi-
lization of the picosecond diode laser. A second example is
the configuration of PTB_2 with its optional diode laser mod-
ules BHLP-700 (Becker & Hickl GmbH). These laser modules
operating at 785 nm were employed in a clinical study of bed-
side monitoring of cerebral perfusion.9 Their fast warm-up time
(about 10 min) and stable behavior were essential for this
application. The high timing stability is achieved by temperature
stabilization of the laser diode and by deriving the
synchronization signal for the TCSPC timing directly from
the pins of the laser diode.
Similar to the approach pursued in the previous section, such
stability measurements can be used to study the impact of drifts
and fluctuations on in vivo measurements. For example, uncer-
tainty in the time origin t0 (the time at which photons enter the
medium) is relevant when fitting models to DTOFs which
assume a known value of t0. The impact of instrumental fluc-
tuations on fNIRS signals can be investigated by applying the
same procedures used for in vivo measurement to IRF stability
measurements, including, for example, block averaging as is
typically performed in functional activation studies. This allows
an estimation to be made of the contribution of the instrumental
fluctuations to measured fNIRS signals.
5 Conclusions
The BIP protocol for time-domain optical brain imagers com-
prises a set of tests addressing the essential characteristics of
all components of the system and most especially of the source
and detector. The present paper introduces the individual tests
and provides guidance for their implementation. While some of
the tests, including the characterization of differential nonlinear-
ity and IRF, are already commonly employed, the responsivity
test has been specifically developed for this protocol. The design
and characterization of the dedicated phantoms produced for
this test were described in detail.
The results presented in this work were focused on the two
particularly relevant measures: responsivity and IRF. The quan-
tification and comparison of the responsivity of several instru-
ments and laboratory setups of four different partner institutions
of the nEUROPt project provided new insights. Since the effi-
ciency of photon detection is essential for achieving a good
Fig. 6 Relative contrast due to a deep absorption perturbation (see
text) for photon counts in time windows of 250-ps width derived from
the DTOFs after convolution with the IRFs shown in Fig. 5(a). For
comparison, the case of a delta-pulse IRF is plotted. The position
of the symbols corresponds to the lower bounds of the respective
time windows.
Fig. 7 An example of stability test for (a) total photon count N tot and
(b) first momentm1 of the IRF for one detector of POLIMI_2, recorded
for 7 h every minute, and of PTB_2 (operated at 785 nm), recorded for
1 h every second, in both cases with a collection time of 1 s and a
count rate of about 106 s−1. The thin dashed lines indicate the ranges
of 0.5% for N tot and 5 ps for m1.
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signal-to-noise ratio in in vivo studies (particularly for dynamic
measurements), the assessment of responsivity is particularly
useful in the process of instrumental development. Subsequent
tests allow possible degradation of detectors or of alignment of
optics in the detection path to be assessed. Furthermore, the dif-
ference between actual responsivity values and values estimated
based on Eq. (2) can facilitate the identification of deficiencies
in the detection system of a diffuse optical instrument.
Moreover, quantitative knowledge of the responsivity of the
instrument could be utilized to derive additional information
from in vivo measurements by quantifying diffuse reflectance
or transmittance of the tissue under investigation for a given
source-detector geometry.
It should be noted that the assessment and interpretation of
the responsivity of the detection system to some extent rely on
the assumption of a Lambertian angular profile for the light exit-
ing the phantom or tissue. This assumption is often invalid,17
particularly when measuring over small (approximately few
millimeter) source-detector separations. In the diffuse regime,
relevant to brain or breast imaging applications, the deviation
from a Lambertian profile depends on the ratio of the refractive
index inside and outside the turbid medium.37 However, for bio-
logical tissue and solid phantoms in air where the ratio is around
1.4 to 1.6, this deviation is no larger than a few percent. The
degree of roughness of the surface of the tissue or phantom
is another factor that may limit the agreement between measure-
ments and simulations of light propagation, in particular the
angular distribution of outgoing radiation.17,37
The measurement of the IRF, the second focus of the present
paper, is highly relevant when assessing the performance of any
time-domain instrument. The width (FWHM) of the IRF is often
used to specify the time resolution. However, this single param-
eter is not sufficient to characterize the entire shape of the IRF
which is highly dependent on the type of detector. In time-
domain brain imaging, longer flight-time photons play an
important role, and thus any afterpeaks and slowly decaying
tails of the IRF are particularly relevant. Hence, the full temporal
profile of the IRF needs to be considered. We demonstrated
the utilization of measured IRFs in simulations to identify
the impact of their shape on the contrast achieved for brain
activation measurements. Apart from its temporal shape, the sta-
bility of the IRF is important, as was illustrated with exemplar
measurements.
The BIP tests can be performed as a stand-alone protocol,
but they also complement the more application-oriented
MEDPHOT and nEUROPt protocols,13,15 and are relevant
when interpreting the results of these protocols. Depending
on the specific algorithm employed for data analysis, the proper-
ties of the instrument (e.g., width of the IRF, drift of laser power,
or timing) may significantly influence the results of the measure-
ments. Robustness against instrumental artifacts is an important
requirement which can be assessed by the combination of basic
and “high-level” tests, complemented by simulations taking into
account the actual instrumental properties.
The BIP protocol was developed with the focus on time-
domain optical brain imagers. Nevertheless, the complete set
of basic instrumental tests can also be applied to the assessment
of other time-domain photon-migration instruments based on
TCSPC technology, such as time-domain optical mammography
systems and diffuse spectrometers. The range of applicability of
some of the individual tests extends even further. The assess-
ment of responsivity is not restricted to time-domain instruments
and can, in principle, be adapted for any instrument that mea-
sures diffuse reflectance or transmittance of tissues. Meanwhile,
the tests which characterize time-resolved measurements (e.g.,
IRF, temporal stability, and differential nonlinearity) and the use
of simulations to assess the influence of nonideal behavior on
measurements could be applied to any TCSPC-based systems,
including instrumentation for recording fluorescence lifetimes.
The BIP protocol was part of a more comprehensive assess-
ment and comparison of time-domain optical brain imagers. The
nEUROPt protocol, a topic of the companion paper,15 is based
on measurements on inhomogeneous phantoms and addresses
the specific capability of these instruments to detect, localize,
and quantify brain activation.
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